iSpecimen Inc. (ISPC) compared with its closest peers (ONMD, ABSI, BIAF, AIDX, BNBX). Peer set by Business Services; 10 comparable business services companies. First-party data.
OneMedNet, Absci, bioAffinity Technologies and OmniAb share iSpecimen's sub-industry, commercial research labs.
| Company | Market Cap | P/E |
|---|---|---|
| OneMedNet Corporation (ONMD) | — | — |
| Absci Corporation (ABSI) | $1.37B | -4.1 |
| bioAffinity Technologies, Inc. (BIAF) | $4.28M | -0.1 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $8.05M | — |
| BNB Plus Corp. (BNBX) | $1.08M | — |
| VolitionRx Limited (VNRX) | $3.15M | — |
| Q/C Technologies, Inc. (QCLS) | $15.68M | -0.5 |
| OmniAb, Inc. (OABI) | $731.31M | -3.2 |
| Insight Molecular Diagnostics Inc. (IMDX) | $131.55M | -4.5 |
| Biomerica, Inc. (BMRA) | $10.05M | -1.4 |
| Sector P/E (Technology) | 31.8 |
| Industry P/E (Business Services) | 28.3 |
ISPC overview · ISPC earnings · ISPC financials · ISPC KPIs · ISPC documents · ISPC ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.